Physician

William Scott Thompson, MD

According to 2025 Medicare claims, William Thompson, MD (NPI: 1396743480) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33308-1909.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 765 traditional Medicare patients, billed 15,865 HCPCS/CPT codes, and received $1,867,756 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 387 prescription claims across 128 beneficiaries totaling $43,383 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 1 records totaling $118. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $145,051 to $43,383. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $2,668,137 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,539,453 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,363,779 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,313,352 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,365,289 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,075,569 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,068,361 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,187,288 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,667,232 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,867,756 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201588114,438$2,668,137
201692912,241$2,539,453
201793312,297$2,363,779
20181,01313,653$2,313,352
201999713,981$2,365,289
202089411,281$2,075,569
202182111,007$2,068,361
202285711,706$2,187,288
202367510,869$1,667,232
202476515,865$1,867,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$73K$145K2015 Drug cost: $145,051 (USD; Tot_Drug_Cst)2016 Drug cost: $101,347 (USD; Tot_Drug_Cst)2017 Drug cost: $45,596 (USD; Tot_Drug_Cst)2018 Drug cost: $40,049 (USD; Tot_Drug_Cst)2019 Drug cost: $35,488 (USD; Tot_Drug_Cst)2020 Drug cost: $29,956 (USD; Tot_Drug_Cst)2021 Drug cost: $33,883 (USD; Tot_Drug_Cst)2022 Drug cost: $35,456 (USD; Tot_Drug_Cst)2023 Drug cost: $31,971 (USD; Tot_Drug_Cst)2024 Drug cost: $43,383 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015155468$145,051
2016127420$101,347
2017126379$45,596
2018127379$40,049
2019135380$35,488
2020118361$29,956
2021118400$33,883
2022120337$35,456
202385302$31,971
2024128387$43,383

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2361,007$103
92014Established patient complete exam of visual system6321,306$99
92012Established patient problem focused exam of visual system191436$73
92134Imaging of retina6791,684$33
92250Photography of the retina162179$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium381,632$12,681
IlevroNepafenac12369$6,555
Bromfenac SodiumBromfenac Sodium24697$4,177
Prednisolone AcetatePrednisolone Acetate734,091$3,490
DifluprednateDifluprednate231,026$2,261

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$118Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for William Scott Thompson, MD?

Tedicare shows public-source Medicare data for William Scott Thompson, MD (NPI 1396743480), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Scott Thompson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William Scott Thompson, MD?

William Scott Thompson, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does William Scott Thompson, MD have Open Payments data?

William Scott Thompson, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.